Eli Lilly and Bristol-Myers Profits Fall on Generic Drug Competition
Thursday, July 26, 2012 - 01:30
in Mathematics & Economics
Eli Lilly beat profit forecasts, but both it and Bristol-Myers Squibb are struggling to make up for loses on several drugs that no longer have patent protection.